Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic protection against ischemic brain damage.

F M Yatsu

    Neurologic Clinics
    |February 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Pharmacologic neuroprotection strategies require careful consideration. This review examines their use and recommendations for stroke, cardiac arrest, and head trauma to prevent ischemic brain damage.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk.

    Journal of neurology, neurosurgery, and psychiatry·2008
    Same author

    Butyrate inhibits proliferation-induced proliferating cell nuclear antigen expression (PCNA) in rat vascular smooth muscle cells.

    Molecular and cellular biochemistry·2000
    Same author

    HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention.

    Neurology·2000
    Same author

    Is cholesterol a risk factor for stroke?: Yes.

    Archives of neurology·1999
    Same author

    Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.

    Stroke·1998
    Same author

    Inhibition of platelet-derived growth factor BB-induced expression of glyceraldehyde-3-phosphate dehydrogenase by sodium butyrate in rat vascular smooth muscle cells.

    Arteriosclerosis, thrombosis, and vascular biology·1998

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Clinical Medicine

    Background:

    • Ischemic brain damage is a critical concern in stroke, cardiac arrest, and head trauma.
    • Pharmacologic interventions are explored for neuroprotection against ischemic injury.

    Observation:

    • The review analyzes the rationale, application, and evidence-based recommendations for pharmacologic neuroprotection.
    • Clinical conditions examined include ischemic stroke, post-cardiac arrest, and traumatic brain injury.

    Findings:

    • Pharmacologic neuroprotection should be implemented with caution due to variable efficacy and potential risks.
    • Evidence and recommendations vary across the different clinical scenarios of ischemic brain damage.

    Implications:

    Related Experiment Videos

    • Cautious application of pharmacologic agents is advised pending further research and clinical validation.
    • Optimizing neuroprotective strategies is crucial for improving patient outcomes in neurological emergencies.